221 related articles for article (PubMed ID: 10942354)
1. Acceptability of a novel vaginal microbicide during a safety trial among low-risk women.
Bentley ME; Morrow KM; Fullem A; Chesney MA; Horton SD; Rosenberg Z; Mayer KH
Fam Plann Perspect; 2000; 32(4):184-8. PubMed ID: 10942354
[TBL] [Abstract][Full Text] [Related]
2. The acceptability of an investigational vaginal microbicide, PRO 2000 Gel, among women in a phase I clinical trial.
Morrow K; Rosen R; Richter L; Emans A; Forbes A; Day J; Morar N; Maslankowski L; Profy AT; Kelly C; Abdool Karim SS; Mayer KH
J Womens Health (Larchmt); 2003 Sep; 12(7):655-66. PubMed ID: 14583106
[TBL] [Abstract][Full Text] [Related]
3. Women's interest in vaginal microbicides.
Darroch JE; Frost JJ
Fam Plann Perspect; 1999; 31(1):16-23. PubMed ID: 10029928
[TBL] [Abstract][Full Text] [Related]
4. Colposcopic evaluation of a vaginal gel formulation of iota-carrageenan.
Elias CJ; Coggins C; Alvarez F; Brache V; Fraser IS; Lacarra M; Lähteenmäki P; Massai R; Mishell DR; Phillips DM; Salvatierra AM
Contraception; 1997 Dec; 56(6):387-9. PubMed ID: 9494773
[TBL] [Abstract][Full Text] [Related]
5. [Current status of the female condom in Africa].
Deniaud F
Sante; 1997; 7(6):405-15. PubMed ID: 9503499
[TBL] [Abstract][Full Text] [Related]
6. User-identified gel characteristics: a qualitative exploration of perceived product efficacy of topical vaginal microbicides.
Morrow KM; Underhill K; van den Berg JJ; Vargas S; Rosen RK; Katz DF
Arch Sex Behav; 2014 Oct; 43(7):1459-67. PubMed ID: 24452632
[TBL] [Abstract][Full Text] [Related]
7. A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases.
Roddy RE; Zekeng L; Ryan KA; Tamoufé U; Weir SS; Wong EL
N Engl J Med; 1998 Aug; 339(8):504-10. PubMed ID: 9709043
[TBL] [Abstract][Full Text] [Related]
8. Microbicide acceptability among high-risk urban U.S. women: experiences and perceptions of sexually transmitted HIV prevention.
Weeks MR; Mosack KE; Abbott M; Sylla LN; Valdes B; Prince M
Sex Transm Dis; 2004 Nov; 31(11):682-90. PubMed ID: 15502677
[TBL] [Abstract][Full Text] [Related]
9. Perceptions of acceptability and utility of microbicides in Ghana, West Africa: a qualitative, exploratory study.
Tanner AE
SAHARA J; 2008 Apr; 5(1):11-8. PubMed ID: 18496615
[TBL] [Abstract][Full Text] [Related]
10. Acceptability of Praneem polyherbal vaginal tablet among HIV uninfected women & their male partners in Pune, India--Phase I study.
Joglekar NS; Joshi SN; Navlakha SN; Katti UR; Mehendale SM
Indian J Med Res; 2006 Apr; 123(4):547-52. PubMed ID: 16783046
[TBL] [Abstract][Full Text] [Related]
11. Patterns of condom use and sexual behavior among never-married women.
Potter LB; Anderson JE
Sex Transm Dis; 1993; 20(4):201-8. PubMed ID: 8211537
[TBL] [Abstract][Full Text] [Related]
12. Acceptability of and Adherence to an Antiretroviral-Based Vaginal Microbicide among Pregnant Women in the United States.
Montgomery ET; Noguchi LM; Dai JY; Pan J; Biggio J; Hendrix C; Isaacs K; Watts DH; Schwartz JL; Piper J; Beigi R
AIDS Behav; 2018 Feb; 22(2):402-411. PubMed ID: 28550377
[TBL] [Abstract][Full Text] [Related]
13. Muslim women's reflections on the acceptability of vaginal microbicidal products to prevent HIV infection.
Hoel N; Shaikh S; Kagee A
Ethn Health; 2011 Apr; 16(2):89-106. PubMed ID: 21328113
[TBL] [Abstract][Full Text] [Related]
14. The role of partnership dynamics in determining the acceptability of condoms and microbicides.
Montgomery CM; Lees S; Stadler J; Morar NS; Ssali A; Mwanza B; Mntambo M; Phillip J; Watts C; Pool R
AIDS Care; 2008 Jul; 20(6):733-40. PubMed ID: 18576176
[TBL] [Abstract][Full Text] [Related]
15. Acceptability and performance of a nonwoven device for vaginal drug delivery among women and their male partners in KwaZulu-Natal, South Africa.
Hart CW; Joanis C; Hartmann M; Milford C; Smit J; Beksinska M; Rambally-Greener L; Pienaar J; Mabude Z; Butterworth GAM; Sokal D; Jenkins D
Eur J Contracept Reprod Health Care; 2019 Oct; 24(5):390-398. PubMed ID: 31517545
[No Abstract] [Full Text] [Related]
16. Perspectives from Young South African and Zimbabwean Women on Attributes of Four (Placebo) Vaginal Microbicide Delivery Forms.
Weinrib R; Browne EN; Shapley-Quinn MK; van der Straten A; Beksinska M; Mgodi N; Musara P; Mphili N; Schwartz JL; Ju S; Hanif H; Montgomery ET;
AIDS Behav; 2020 Feb; 24(2):637-647. PubMed ID: 31254190
[TBL] [Abstract][Full Text] [Related]
17. Safety and acceptability of the candidate microbicide Carraguard in Thai Women: findings from a Phase II Clinical Trial.
Kilmarx PH; van de Wijgert JH; Chaikummao S; Jones HE; Limpakarnjanarat K; Friedland BA; Karon JM; Manopaiboon C; Srivirojana N; Yanpaisarn S; Supawitkul S; Young NL; Mock PA; Blanchard K; Mastro TD
J Acquir Immune Defic Syndr; 2006 Nov; 43(3):327-34. PubMed ID: 16980907
[TBL] [Abstract][Full Text] [Related]
18. A randomized, placebo-controlled trial to assess the safety and acceptability of use of carraguard vaginal gel by heterosexual couples in Thailand.
Kilmarx PH; Blanchard K; Chaikummao S; Friedland BA; Srivirojana N; Connolly C; Witwatwongwana P; Supawitkul S; Mock PA; Chaowanachan T; Tappero J
Sex Transm Dis; 2008 Mar; 35(3):226-32. PubMed ID: 18490865
[TBL] [Abstract][Full Text] [Related]
19. A randomized controlled safety and acceptability trial of dextrin sulphate vaginal microbicide gel in sexually active women in Uganda.
Bakobaki JM; Lacey CJ; Bukenya MI; Nunn AJ; McCormack S; Byaruhanga RN; Okong P; Namukwaya SW; Grosskurth H; Whitworth JA
AIDS; 2005 Dec; 19(18):2149-56. PubMed ID: 16284465
[TBL] [Abstract][Full Text] [Related]
20. Acceptability of formulations and application methods for vaginal microbicides among drug-involved women: results of product trials in three cities.
Hammett TM; Mason TH; Joanis CL; Foster SE; Harmon P; Robles RR; Finlinson HA; Feudo R; Vining-Bethea S; Jeter G; Mayer KH; Doherty-Iddings P; Seage GR
Sex Transm Dis; 2000 Feb; 27(2):119-26. PubMed ID: 10676980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
